Bleeding Gums, Sick Arteries — The Periodontal-Vascular Axis

Presentation

240 SA adults aged 40-65 with periodontitis (probing depth ≥4mm in ≥30% of sites) and at least one CV risk factor (T2D, hypertension, family history, hsCRP >3) randomized 1:1 to intensive periodontal therapy (scaling, root planing, antimicrobials, surgical when needed) vs control (standard hygiene visit + brushing instructions). Outcome measures at 6 months: serum IL-6, hsCRP, HbA1c, flow-mediated dilation (FMD), and ambulatory BP.

Key Finding

Intensive arm: IL-6 fell 38% (3.2 → 2.0 pg/mL); hsCRP fell 31%; HbA1c fell 0.4%; FMD improved from 4.8% to 6.1%; systolic BP fell 5 mmHg. Control arm: minimal changes. The magnitude of FMD improvement was equivalent to that achieved by initiating a statin — for a single non-pharmacologic intervention.

Intervention & Outcome

Intensive arm received: full-mouth scaling and root planing within 24 hours, locally delivered minocycline gel in deep pockets, periodontal surgery for residual >5mm pockets at 3 months, and 3-monthly maintenance. Control received standard prophylaxis and oral hygiene instructions only.

First Principles

Periodontal pathogens (Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans) and their LPS enter circulation through ulcerated gingival epithelium. Hepatocytes respond by producing IL-6, CRP, and fibrinogen. Endothelial cells exposed to circulating LPS develop dysfunction. The cycle creates chronic, low-grade systemic inflammation. Treating periodontitis removes a major source of bacterial load and inflammatory signal — measurably reducing systemic markers within months.